Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501).

Authors

null

Yoshiaki Iwasaki

Department of Surgery, IMS Tokyo-Katsushika General Hospital, Tokyo, Japan

Yoshiaki Iwasaki , Masanori Terashima , Junki Mizusawa , Hiroshi Katayama , Kenichi Nakamura , Hitoshi Katai , Takaki Yoshikawa , Yuichi Ito , Masahide Kaji , Yutaka Kimura , Motohiro Hirao , Makoto Yamada , Akira Kurita , Masakazu Takagi , Masahiro Gotoh , Akinori Takagane , Hiroshi Yabusaki , Naoki Hirabayashi , Takeshi Sano , Mitsuru Sasako

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

C000000279

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4046)

DOI

10.1200/JCO.2018.36.15_suppl.4046

Abstract #

4046

Poster Bd #

235

Abstract Disclosures